Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PRKD3 | O94806 | 2/20 | 0.57 |
| ▸ | PRKD1 | Q15139 | 2/20 | 0.57 |
| ▸ | PRKD2 | Q9BZL6 | 2/20 | 0.57 |
| ▸ | AAK1 | Q2M2I8 | 8/20 | 0.41 |
| ▸ | MKNK1 | Q9BUB5 | 1/20 | 0.38 |
| ▸ | MKNK2 | Q9HBH9 | 1/20 | 0.38 |
| ▸ | SYK | P43405 | 2/20 | 0.38 |
| ▸ | MAP4K4 | O95819 | 1/20 | 0.37 |
| ▸ | CYP3A4 | P08684 | 6/20 | 0.37 |
| ▸ | CIT | O14578 | 1/20 | 0.37 |
| ▸ | CHEK1 | O14757 | 1/20 | 0.36 |
| ▸ | CHEK2 | O96017 | 1/20 | 0.36 |
| ▸ | FYN | P06241 | 1/20 | 0.36 |
| ▸ | CTSS | P25774 | 1/20 | 0.36 |
| ▸ | CTSK | P43235 | 1/20 | 0.36 |
| ▸ | TTK | P33981 | 1/20 | 0.36 |
| ▸ | MYC | P01106 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4501837 | 1.00 | PRKD3 (0.57) | PRKD3PRKD1PRKD2AAK1MKNK1 | |
| SCHEMBL4501859 | 1.00 | PRKD3 (0.57) | PRKD3PRKD1PRKD2AAK1MKNK1 | |
| SCHEMBL4520461 | 0.89 | PRKD3 (0.59) | PRKD3PRKD1PRKD2AAK1CYP3A4 | |
| SCHEMBL4520464 | 0.89 | PRKD3 (0.59) | PRKD3PRKD1PRKD2AAK1CYP3A4 | |
| SCHEMBL4502127 | 0.89 | PRKD3 (0.59) | PRKD3PRKD1PRKD2AAK1CYP3A4 | |
| SCHEMBL4502113 | 0.89 | PRKD3 (0.59) | PRKD3PRKD1PRKD2AAK1CYP3A4 | |
| SCHEMBL4502119 | 0.89 | PRKD3 (0.59) | PRKD3PRKD1PRKD2AAK1CYP3A4 | |
| SCHEMBL4520466 | 0.89 | PRKD3 (0.59) | PRKD3PRKD1PRKD2AAK1CYP3A4 | |
| SCHEMBL8230957 | 0.88 | PRKD3 (0.48) | PRKD3PRKD1PRKD2AAK1MKNK1 | |
| SCHEMBL4517488 | 0.83 | PRKD3 (0.53) | PRKD3PRKD1PRKD2SYKCYP3A4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20090247519-A1 | AMINO-ETHYL-AMINO-ARYL (AEAA) COMPOUNDS AND THEIR USE | CANCER RESEARCH TECHNOLOGY LIMITED (GB) | 2009-10-01 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090247519-A1 | AMINO-ETHYL-AMINO-ARYL (AEAA) COMPOUNDS AND THEIR USE | PKD2, PKD1, AADAT | PRKD3 9/4885PRKD1 49/4885PRKD2 18/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.